Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nunn

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|January 12, 2007
In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubataNatalie J Hepburn, Anwen S Williams, Miles A Nunn, et al.
Scientific Reports|November 24, 2017
Structural basis of cholesterol binding by a novel clade of dendritic cell modulators from ticksPietro Roversi, Steven Johnson, Stephen G Preston, et al.
Pharmaceutical Research|September 20, 2014
An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonatesH Mulla, S Yakkundi, J McElnay, et al.
British Journal of Pharmacology|February 9, 2006
Purinoceptors as therapeutic targets for lower urinary tract dysfunctionAnthony P D W Ford, Joel R Gever, Philip A Nunn, et al.
Academic Radiology|May 22, 2002
Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agentsEdmund R Marinelli, Richard Neubeck, Bo Song, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humansAndreas Barratt-Due, Ebbe Billmann Thorgersen, Julie Katrine Lindstad, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 9, 1998
Prevalence of tuberculosis in TB suspects with short duration of coughH T Banda, A D Harries, S Welby, et al.
Frontiers in Pharmacology|March 30, 2022
Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in MiceIbrahim Alrashdi, Amal Alsubaiyel, Michele Chan, et al.
British Journal of Clinical Pharmacology|June 22, 2017
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteersPatrick F Smith, Janakan Krishnarajah, Philip A Nunn, et al.
JMIR Mhealth and Uhealth|June 21, 2017
A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled TrialShivani Goyal, Caitlin A Nunn, Michael Rotondi, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|January 12, 2007
In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubataNatalie J Hepburn, Anwen S Williams, Miles A Nunn, et al.
Scientific Reports|November 24, 2017
Structural basis of cholesterol binding by a novel clade of dendritic cell modulators from ticksPietro Roversi, Steven Johnson, Stephen G Preston, et al.
Pharmaceutical Research|September 20, 2014
An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonatesH Mulla, S Yakkundi, J McElnay, et al.
British Journal of Pharmacology|February 9, 2006
Purinoceptors as therapeutic targets for lower urinary tract dysfunctionAnthony P D W Ford, Joel R Gever, Philip A Nunn, et al.
Academic Radiology|May 22, 2002
Synthesis and evaluation of macrocyclic gadolinium chelates as hepatospecific MRI agentsEdmund R Marinelli, Richard Neubeck, Bo Song, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humansAndreas Barratt-Due, Ebbe Billmann Thorgersen, Julie Katrine Lindstad, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|October 9, 1998
Prevalence of tuberculosis in TB suspects with short duration of coughH T Banda, A D Harries, S Welby, et al.
Frontiers in Pharmacology|March 30, 2022
Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in MiceIbrahim Alrashdi, Amal Alsubaiyel, Michele Chan, et al.
British Journal of Clinical Pharmacology|June 22, 2017
A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteersPatrick F Smith, Janakan Krishnarajah, Philip A Nunn, et al.
JMIR Mhealth and Uhealth|June 21, 2017
A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled TrialShivani Goyal, Caitlin A Nunn, Michael Rotondi, et al.
Pageof 13